A Halifax company is making progress in the fight against infectious diseases. MedMira’s newly manufactured HIV-Syphilis ...

Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune system. It essentially hacks the immune cells, transferring its own faulty ...

The rising global incidence of syphilis underscores the risk of transmission through blood transfusions. Treponema pallidum, the pathogen responsible for syphilis, represents a major public health ...

The Antibodies mod enhances the vanilla zombification mechanic by introducing an antibodies curve inspired by real-life immune system responses. If the antibodies successfully counteract the infection ...

aHKU-Pasteur Research Pole, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China bWorld Health Organization Collaborating Centre for Infectious Disease ...

It uses a unique mechanism of twice-yearly injections to treat individuals with multidrug-resistant HIV. It noted that it was “a pivotal step toward diminishing HIV/AIDS as a global health ...

The future may be getting brighter in terms of reducing the threat of the human immunodeficiency virus (HIV), infectious disease experts told Newsweek. With new treatments and maybe even a vaccine ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to ...